LH - Laboratory Corporation of America Holdings

NYSE - NYSE Delayed Price. Currency in USD
153.96
+2.67 (+1.76%)
At close: 4:02PM EDT

153.96 0.00 (0.00%)
After hours: 6:08PM EDT

Stock chart is not supported by your current browser
Previous Close151.29
Open151.13
Bid154.56 x 800
Ask154.60 x 800
Day's Range150.89 - 155.13
52 Week Range119.38 - 190.36
Volume766,616
Avg. Volume768,835
Market Cap15.192B
Beta (3Y Monthly)1.21
PE Ratio (TTM)17.88
EPS (TTM)8.61
Earnings DateApr 30, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date1994-03-29
1y Target Est168.74
Trade prices are not sourced from all markets
  • LabCorp (LH) Expected to Beat Earnings Estimates: Should You Buy?
    Zacksyesterday

    LabCorp (LH) Expected to Beat Earnings Estimates: Should You Buy?

    LabCorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GlobeNewswire2 days ago

    OmniSeq and LabCorp Extend Exclusive Distribution Pact and Complete Follow-On Investment Agreement

    OmniSeq®, a CAP-accredited, molecular diagnostics spin-out of Roswell Park Comprehensive Cancer Center, and LabCorp® (LH), a leading global life sciences company, announced today an extension of their exclusive distribution agreement as well as an additional investment by LabCorp. The distribution agreement and LabCorp’s initial investment in OmniSeq’s Series B financing round were first announced in August 2017. The distribution agreement originally provided LabCorp with exclusive distribution rights for the OmniSeq Comprehensive and Immune Report Card clinical assays.

  • Moody's2 days ago

    Envigo Laboratories Inc. -- Moody's announces completion of a periodic review of ratings of Envigo Laboratories Inc.

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Envigo Laboratories Inc. New York, April 22, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Envigo Laboratories Inc. ("Envigo") and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • Moody's2 days ago

    Envigo Laboratories Inc. -- Moody's places Envigo's ratings under review for upgrade following LabCorp deal announcement

    Moody's Investors Service ("Moody's") placed the ratings of Envigo Laboratories Inc. under review for upgrade. Ratings under review for upgrade include the Caa2 Corporate Family Rating, Caa2-PD Probability of Default Rating, the B3 senior secured first lien credit facilities and Caa3 senior secured second lien credit facilities. The announced sale of Envigo's nonclinical contract research services business to LabCorp and the concurrent acquisition of LabCorp's US research models and services business is credit positive given the improvement in liquidity due to net proceeds to be received of $485 million.

  • Moody's5 days ago

    Laboratory Corporation of America Holdings -- Moody's announces completion of a periodic review of ratings of Laboratory Corporation of America Holdings

    Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Laboratory Corporation of America Holdings and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.

  • Thermo Fisher (TMO) to Report Q1 Earnings: What's in Store?
    Zacks6 days ago

    Thermo Fisher (TMO) to Report Q1 Earnings: What's in Store?

    Strong analytical instruments business, product portfolio expansion and prudent growth strategy are likely to support Thermo Fisher (TMO) in Q1. However, forex might act as a dampener.

  • What's in Store for Align Technology (ALGN) in Q1 Earnings?
    Zacks6 days ago

    What's in Store for Align Technology (ALGN) in Q1 Earnings?

    Higher Invisalign case volume, solid show by Clear Aligner segment and anticipated sturdy growth at Scanner and Service business are likely to support Align Technology (ALGN) in Q1. However, operating expenses are likely to act as dampeners.

  • Laboratory Corporation of America Holdings (NYSE:LH) Has A ROE Of 13%
    Simply Wall St.7 days ago

    Laboratory Corporation of America Holdings (NYSE:LH) Has A ROE Of 13%

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. To keep the lesson grounded in practicality, we'l...

  • LabCorp and Envigo Sign Innovative Agreement to Expand Covance’s Nonclinical Drug Development Capabilities and Create an Independent Research Models Provider
    Business Wire7 days ago

    LabCorp and Envigo Sign Innovative Agreement to Expand Covance’s Nonclinical Drug Development Capabilities and Create an Independent Research Models Provider

    BURLINGTON, N.C. & EAST MILLSTONE, N.J.-- -- LabCorp will purchase Envigo’s nonclinical contract research services business, expanding the global reach and capabilities of Covance’s nonclinical drug development business Envigo’s research models and services business will purchase Covance’s research products business located in the United States, combining two complementary businesses into a new comprehensive ...

  • Sherwin-Williams Shareholders Elect New Directors
    PR Newswire7 days ago

    Sherwin-Williams Shareholders Elect New Directors

    Kerrii B. Anderson, former CEO and President of Wendy's International, Inc., and Jeff M. Fettig, former Chairman and CEO of Whirlpool Corporation, join the Board CLEVELAND , April 17, 2019 /PRNewswire/ ...

  • 3 Stocks That Survived Reverse Splits
    Motley Fool13 days ago

    3 Stocks That Survived Reverse Splits

    Rite Aid's board clears the way for a 1-for-20 reverse stock split later this month. Booking Holdings, LabCorp, and Citi have gone on to move higher after going this route.

  • LabCorp (LH)-QIAGEN Form Alliance in In-Vitro Diagnostics
    Zacks20 days ago

    LabCorp (LH)-QIAGEN Form Alliance in In-Vitro Diagnostics

    LabCorp's (LH) wide exposure in the companion diagnostics space further enhances QIAGEN's personalized health collaborations with the pharmaceutical bigwigs.

  • Walgreens Boots Alliance (WBA) Q2 2019 Earnings Conference Call Transcript
    Motley Fool22 days ago

    Walgreens Boots Alliance (WBA) Q2 2019 Earnings Conference Call Transcript

    WBA earnings call for the period ending February 28, 2019.

  • Did Hedge Funds Drop The Ball On Laboratory Corp. of America Holdings (LH) ?
    Insider Monkey23 days ago

    Did Hedge Funds Drop The Ball On Laboratory Corp. of America Holdings (LH) ?

    After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms' equity portfolios as of December 31. The results of that effort will be put on display in this article, as […]

  • What does Laboratory Corporation of America Holdings's (NYSE:LH) Balance Sheet Tell Us About Its Future?
    Simply Wall St.23 days ago

    What does Laboratory Corporation of America Holdings's (NYSE:LH) Balance Sheet Tell Us About Its Future?

    Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Investors seeking to preserve capital in a volatile environment might consider large-cap stocks such as Laboratory Corporatio...

  • Business Wire23 days ago

    LabCorp to Announce First Quarter Financial Results on April 30, 2019

    LabCorp® (LH) will release its first quarter of 2019 financial results before the market opens on Tuesday, April 30, 2019, followed by a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results. Interested parties can access the conference call by dialing 844-634-1444 within the U.S. and Canada, or 1-615-247-0253 internationally, using the passcode 7459328. An audio replay of the conference call will be available from 1:00 p.m. EDT on April 30, 2019, until 11:30 a.m. EDT on May 14, 2019, by dialing 855-859-2056 within the U.S. and Canada, or 1-404-537-3406 internationally, using the passcode 7459328.

  • Business Wire23 days ago

    Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021

    LabCorp® (LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject to the terms of the Zero Coupon Notes and the Indenture, dated as of Oct. 24, 2006, between LabCorp and The Bank of New York Mellon, as trustee (Trustee) and the conversion agent.

  • LabCorp Earns 100 Percent on Human Rights Campaign Foundation’s 17th Annual Scorecard on LGBTQ Workplace Equality
    Business Wire27 days ago

    LabCorp Earns 100 Percent on Human Rights Campaign Foundation’s 17th Annual Scorecard on LGBTQ Workplace Equality

    LabCorp® (LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it received a perfect score of 100 on the 2019 Corporate Equality Index (CEI), the nation’s premier benchmarking survey and report on corporate policies and practices related to LGBTQ workplace equality, administered by the Human Rights Campaign (HRC) Foundation. “It is an honor to receive this recognition for a second consecutive year because of the commitment of our nearly 61,000 colleagues worldwide to creating a positive work environment and culture,” said David P. King, chairman and CEO of LabCorp.

  • GlobeNewswire29 days ago

    Recent Analysis Shows Transocean, Chipotle Mexican Grill, Marathon Oil, Laboratory Corporation of America, Bio-Rad Laboratories, and Graco Market Influences — Renewed Outlook, Key Drivers of Growth

    NEW YORK, March 27, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • Should Value Investors Consider Laboratory Corporation (LH)?
    Zacks29 days ago

    Should Value Investors Consider Laboratory Corporation (LH)?

    Laboratory Corporation (LH) stock may be a good choice for value-oriented investors right now from multiple angles.

  • How Do Analysts See Laboratory Corporation of America Holdings (NYSE:LH) Performing In The Next 12 Months?
    Simply Wall St.last month

    How Do Analysts See Laboratory Corporation of America Holdings (NYSE:LH) Performing In The Next 12 Months?

    As Laboratory Corporation of America Holdings (NYSE:LH) announced its earnings release on 31 December 2018, analyst forecasts seem fairly subdued, with profits predicted to rise by 3.6% next year againstRead More...

  • Markitlast month

    See what the IHS Markit Score report has to say about Laboratory Corporation of America Holdings.

    Laboratory Corporation of America Holdings NYSE:LHView full report here! Summary * Perception of the company's creditworthiness is negative * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for LH with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting LH. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold LH had net inflows of $3.95 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. LH credit default swap spreads are near their highest levels for the past 1 year, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Business Wirelast month

    LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

    LabCorp® (LH) announced today that for the period of March 11, 2019 to Sept. 10, 2019, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will accrue (subject to the terms of the Zero Coupon Notes) contingent cash interest at a rate of no less than 0.125% of the average market price of a Zero Coupon Note for the five trading days ended March 6, 2019, in addition to the continued accrual of the original issue discount. Contingent cash interest, which the Company has determined to be approximately $2.47 per Note, will be payable to holders of the Zero Coupon Notes as of the record date, which is Aug. 27, 2019. The payment of contingent cash interest is expected to be made on Sept. 11, 2019.

  • Why Is LabCorp (LH) Down 0.6% Since Last Earnings Report?
    Zacks2 months ago

    Why Is LabCorp (LH) Down 0.6% Since Last Earnings Report?

    LabCorp (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Business Wire2 months ago

    LabCorp is Scheduled to Present at the 2019 Barclays Global Healthcare Conference

    LabCorp® (LH) today announced it will participate at the 2019 Barclays Global Healthcare Conference. LabCorp’s presentation is planned for Tuesday, March 12, 2019, at 8:30 a.m. (ET). A live audio webcast of the presentation will be available via the Company website at www.LabCorp.com and archived for replay.